Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New DNA tests to help prevent blindness in border collies
"We hope our research will help to reduce the number of dogs that go blind from this disease.”
Genetic mutation found to be responsible for severe gonio 

Scientists have discovered a mutation in the OLFML3 gene which causes sudden blindness in border collies.

The findings have resulted in several companies developing genetic tests for the condition, called goniodysgenesis - or gonio - to avoid affected dogs being used to produce puppies.

In severe gonio, the affected dog’s eyes do not develop properly, which can cause glaucoma, leading to sudden loss of sight. Sudden blindness in border collies was first seen in Australia in the late 90s, then in the UK in relatives of the original dogs. Breeders suspected there may be a genetic cause.

Researchers from the Roslin Institute collected DNA from dog saliva samples and compared those with healthy eyes, to those with symptoms of severe gonio. They found a genetic mutation in OLFML3, which is involved in the early stages of eyeball development.

All dogs who suffered blindness had two copies of the mutation gene. The research paper has been published in the journal G3: Genes, Genomes, Genetics.

Dr Carys Pugh, from the University of Edinburgh, said: “We are delighted that our findings have directly led to a genetic test for this condition. We hope our research will help to reduce the number of dogs that go blind from this disease.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.